1. 3D‐QSAR and scaffold hopping based designing of benzo[d]ox‐azol‐2(3H)‐one and 2‐oxazolo[4, 5‐b]pyridin‐2(3H)‐one derivatives as selective aldehyde dehydrogenase 1A1 inhibitors: Synthesis and biological evaluation. Issue 9 (26th May 2022) Authors: Verma, Himanshu; Narendra, Gera; Raju, Baddipadige; Kumar, Manoj; Jain, Subheet K.; Tung, Gurleen K.; Singh, Pankaj K.; Silakari, Om Journal: Archiv der Pharmazie Issue: Volume 355:Issue 9(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chemical classes targeting energy supplying GyrB domain of Mycobacterium tuberculosis. (December 2018) Authors: Kashyap, Aanchal; Singh, Pankaj Kumar; Silakari, Om Journal: Tuberculosis Issue: Volume 113(2018) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ChemInform Abstract: Acetylcholinesterase Inhibitors as Alzheimer Therapy: From Nerve Toxins to Neuroprotection. Issue 10 (11th March 2014) Authors: Singh, Manjinder; Kaur, Maninder; Kukreja, Hitesh; Chugh, Rajan; Silakari, Om; Singh, Dhandeep Journal: ChemInform Issue: Volume 45:Issue 10(2014) Page Start: no Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ChemInform Abstract: Flavones: An Important Scaffold for Medicinal Chemistry. Issue 39 (23rd September 2014) Authors: Singh, Manjinder; Kaur, Maninder; Silakari, Om Journal: ChemInform Issue: Volume 45:Issue 39(2014) Page Start: no Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. ChemInform Abstract: Multifunctional Compounds: Smart Molecules for Multifactorial Diseases. Issue 22 (3rd June 2014) Authors: Bansal, Yogita; Silakari, Om Journal: ChemInform Issue: Volume 45:Issue 22(2014) Page Start: no Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. ChemInform Abstract: Oxindole: A Chemical Prism Carrying Plethora of Therapeutic Benefits. Issue 47 (3rd November 2016) Authors: Kaur, Maninder; Singh, Manjinder; Chadha, Navriti; Silakari, Om Journal: ChemInform Issue: Volume 47:Issue 47(2016) Page Start: no Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Concepts and experimental protocols of modelling and informatics in drug design. (2020) Authors: Silakari, Om; Singh, Pankaj Kumar Record Type: Book Extent: 1 online resource, illustrations (black and white, and colour) View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Corrigendum to "Exploration of multi-target potential of chromen-4-one based compounds in Alzheimer's disease: Design, synthesis and biological evaluations" [Bioorg. Med. Chem. 25 (2017) 6273–6285]. Issue 14 (7th August 2018) Authors: Singh, Manjinder; Kaur, Maninder; Singh, Nirmal; Silakari, Om Journal: Bioorganic & medicinal chemistry Issue: Volume 26:Issue 14(2018) Page Start: 4360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Decoding the signature of molecular mechanism involved in mutation associated resistance to 1, 3-benzothiazin-4-ones (Btzs) based DprE1 inhibitors using BTZ043 as a reference drug. Issue 18 (12th December 2019) Authors: Verma, Himanshu; Choudhary, Shalki; Singh, Pankaj Kumar; Kashyap, Aanchal; Silakari, Om Journal: Molecular simulation Issue: Volume 45:Issue 18(2019) Page Start: 1515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Design, synthesis and biological evaluation of novel 2-phenyl-1-benzopyran-4-one derivatives as potential poly-functional anti-Alzheimer's agents. Issue 110 (15th November 2016) Authors: Singh, Manjinder; Silakari, Om Journal: RSC advances Issue: Volume 6:Issue 110(2016) Page Start: 108411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗